Contamination of the medicinal product with trace amounts of N-nitrosodimethylamine (NDMA) in the ranitidine-containing solution for injection. Potential effects: carcinogenic and toxic effects, possible health risk.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the listed batches; if in possession, return it to a pharmacy and, in case of doubts or worrying symptoms, consult a doctor.
The Chief Pharmaceutical Inspector withdrew the specified batches of Ranic from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related